Bladder cancer clinical trials.

Bladder cancer clinical trials.

Item
http://www.wikidata.org/entity/Q36194232
Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancerPathobiology and chemoprevention of bladder cancerDecreased expression of protein tyrosine phosphatase non-receptor type 12 is involved in the proliferation and recurrence of bladder transitional cell carcinoma.Treatment of high-risk, non-muscle-invasive bladder cancer.Molecular targets and targeted therapies in bladder cancer management.Molecular biomarkers for urothelial carcinoma of the bladder: challenges in clinical use.Chemoprevention in bladder cancer: What's new?Urinary protein biomarkers of cancer.The future of bladder cancer care in the USA.A review of recent developments on micro/nanostructured pharmaceutical systems for intravesical therapy of the bladder cancer.Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy.
P2860

Bladder cancer clinical trials.

Item
http://www.wikidata.org/entity/Q36194232
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Bladder cancer clinical trials.
@ast
Bladder cancer clinical trials.
@en
type
label
Bladder cancer clinical trials.
@ast
Bladder cancer clinical trials.
@en
prefLabel
Bladder cancer clinical trials.
@ast
Bladder cancer clinical trials.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Bladder cancer clinical trials.
@en
P2093
P304
P31
P356
10.1016/J.UROLONC.2005.05.005
P433
P478
P577
P698